A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease - Contacts and Locations

A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

This study has been completed.

Study NCT00000729. Last updated on June 23, 2005. Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000729

Locations


United States, California
	Univ of California / San Diego Treatment Ctr
	San Diego, California, United States, 921036325
	Los Angeles County - USC Med Ctr
	Los Angeles, California, United States, 90033
	USC School of Medicine / Norris Cancer Hosp
	Los Angeles, California, United States, 90033

United States, Minnesota
	Univ of Minnesota
	Minneapolis, Minnesota, United States, 55455

United States, New York
	SUNY - Stony Brook
	Stony Brook, New York, United States, 117948153
	Mem Sloan - Kettering Cancer Ctr
	New York, New York, United States, 10021
	Mount Sinai Med Ctr
	New York, New York, United States, 10029
	City Hosp Ctr at Elmhurst / Mount Sinai Hosp
	Elmhurst, New York, United States, 11373

United States, Ohio
	Ohio State Univ Hosp Clinic
	Columbus, Ohio, United States, 432101228

United States, South Carolina
	Julio Arroyo
	West Columbia, South Carolina, United States, 29169

United States, Washington
	Univ of Washington
	Seattle, Washington, United States, 98105

Sponsors and Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Investigators


Study Chair:	Collier AC